Literature DB >> 31152087

Another piece of the puzzle added to understand t(4;11) leukemia better.

Rolf Marschalek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31152087      PMCID： PMC6545855          DOI： 10.3324/haematol.2018.213397

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.

Authors:  A Benedikt; S Baltruschat; B Scholz; A Bursen; T N Arrey; B Meyer; L Varagnolo; A M Müller; M Karas; T Dingermann; R Marschalek
Journal:  Leukemia       Date:  2010-10-29       Impact factor: 11.528

2.  CDK6 is a regulator of stem cells "Egr" to wake up.

Authors:  Monica L Guzman
Journal:  Blood       Date:  2015-01-01       Impact factor: 22.113

3.  Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  Huining Kang; Carla S Wilson; Richard C Harvey; I-Ming Chen; Maurice H Murphy; Susan R Atlas; Edward J Bedrick; Meenakshi Devidas; Andrew J Carroll; Blaine W Robinson; Ronald W Stam; Maria G Valsecchi; Rob Pieters; Nyla A Heerema; Joanne M Hilden; Carolyn A Felix; Gregory H Reaman; Bruce Camitta; Naomi Winick; William L Carroll; ZoAnn E Dreyer; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

4.  DDX6 transfers P-TEFb kinase to the AF4/AF4N (AFF1) super elongation complex.

Authors:  Fabian Mück; Silvia Bracharz; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2016-09-15

5.  The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.

Authors:  Adelheid Bursen; Karen Schwabe; Brigitte Rüster; Reinhard Henschler; Martin Ruthardt; Theo Dingermann; Rolf Marschalek
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

6.  Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.

Authors:  C Caslini; A Serna; V Rossi; M Introna; A Biondi
Journal:  Leukemia       Date:  2004-06       Impact factor: 11.528

7.  Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants.

Authors:  Ronald W Stam; Pauline Schneider; Jill A P Hagelstein; Marieke H van der Linden; Dominique J P M Stumpel; Renee X de Menezes; Paola de Lorenzo; Maria G Valsecchi; Rob Pieters
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

8.  Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients.

Authors:  Luca Trentin; Marco Giordan; Theo Dingermann; Giuseppe Basso; Geertruy Te Kronnie; Rolf Marschalek
Journal:  Eur J Haematol       Date:  2009-06-25       Impact factor: 2.997

9.  The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism.

Authors:  Alessa Kühn; Denise Löscher; Rolf Marschalek
Journal:  Oncotarget       Date:  2016-06-07

10.  Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.

Authors:  Antonio Agraz-Doblas; Clara Bueno; Rachael Bashford-Rogers; Anindita Roy; Pauline Schneider; Michela Bardini; Paola Ballerini; Gianni Cazzaniga; Thaidy Moreno; Carlos Revilla; Marta Gut; Maria G Valsecchi; Irene Roberts; Rob Pieters; Paola De Lorenzo; Ignacio Varela; Pablo Menendez; Ronald W Stam
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941
View more
  2 in total

1.  Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.

Authors:  Joseph P Loftus; Anella Yahiaoui; Patrick A Brown; Lisa M Niswander; Asen Bagashev; Min Wang; Allyson Schauf; Stacey Tannheimer; Sarah K Tasian
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

2.  The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11).

Authors:  Arpita Kundu; Eric Kowarz; Rolf Marschalek
Journal:  Oncogene       Date:  2021-08-05       Impact factor: 9.867
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.